← k3vl4r
Log inGet started →

ONCY (Oncolytics Biotech Inc) Price Forecast

AI-generated price forecast for Oncolytics Biotech Inc (ONCY) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of November 2026: K3vl4r's calibrated AI forecast currently reads ONCY as 1/1 bearish across its horizons (0 of 1 timeframes pointing up), with a last price of 0.4107. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

0.4107

AI outlook

1/1 bearish

Timeframes up

0 / 1

Share𝕏PostTelegram

ONCY forecast by horizon

HorizonDirectionCalibrated move (end of horizon)
1-hour——
4-hour——
Daily~4 weeks out▼ Down-57.41%
WeeklyNot enough track record yet—

Calibrated: each horizon's forecast is weighted by how often the model has called ONCY's direction correctly over the last 30 days, and reversed where it has been wrong more often than right. A horizon votes only once it has enough resolved forecasts.

Latest ONCY news

From the market-news feed the forecasts are read against.

  • Pelareorep Induces Coordinated Antiviral Immune Responses and Enhanced Antitumor Immunity in Multiple Myeloma Patients · Yahoo · Nov 9
  • Translational Data from Anal Cancer Patients Show Pelareorep Drives HPV-Specific Immune Responses, Supporting its Potential Across HPV-Driven Cancers · Yahoo · Nov 4
  • Oncolytics Biotech Announces New Translational Data From An Ongoing Study Showing Pelareorep’s Ability To Increase HPV-16-Specific T Cell Clones And Tumor-Infiltrating Lymphocyte Clones In Second-Line Or Later Squamous Cell Anal Cancer Patients; Immune Activation Levels More Than Doubled In Nearly All Patients After One Cycle Of Treatment; Substantial Increases In HPV-16-Specific T Cells And Tumor-Infiltrating Lymphocytes Observed When Pelareorep Is Combined With A Checkpoint Inhibitor · Benzinga · Nov 4
  • Oncolytics Biotech® Reports Strong Durability and Survival Data in Anal Cancer, Positioning Pelareorep as Potential Backbone Immunotherapy Across HPV-Driven Cancers | ONCY Stock News · ldr:stocktitan.net · Oct 27
  • Oncolytics Biotech® Reports Strong Durability and Survival Data in Anal Cancer, Positioning Pelareorep as Potential Backbone Immunotherapy Across HPV-Driven Cancers · Yahoo · Oct 27

🔒

See the full ONCY forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

ONCY forecast — frequently asked

Will ONCY go up?

K3vl4r's calibrated AI forecast currently reads ONCY as 1/1 bearish — 0 of 1 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the ONCY price prediction for 2026?

K3vl4r's model projects ONCY toward $0.1753 over the next ~4 weeks, a -57.4% move from $0.4116. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

SABSERNAALCLRMRLNTHCYPHQUCYZYMEHURAVANICANFGTBPGHCNTX

Will ONCY reach…?

Will ONCY reach $0.5000?Will ONCY reach $1.00?Will ONCY reach $2.00?Will ONCY reach $3.00?

Or see the full ONCY price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare ONCY

ONCY vs SABSONCY vs ERNAONCY vs ALCONCY vs LRMRONCY vs LNTHONCY vs CYPH

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rResearch libraryTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.